EARLY-PREG: A Preconception Cohort Study Based on Counterfactuals to Study Maternal-Embryonic Molecular Interactions
Recruiting
Observational Study
Early Pregnancy
Early Pregnancy Loss
Childbirth
Healthy
Pregnancy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 40
- Sex
- Female
- Study type
- Observational
- Participants needed
- 223 (estimated)
- Sponsor
- MELISA Institute Genomics & Proteomics Research SpA · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
EARLY-PREG is an open-cohort clinical study with a preconception, longitudinal, bidirectional and counterfactual design. The aim of this cohort is to investigate the proteomic signatures of maternal-embryonic communication by interrogating a growing biorepository of maternal fluids and tissues collected during the first two weeks after fertilisation.
Participants in the EARLY-PREG cohort consist …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* being between 18 and 40 years of age
* not being pregnant
* normal colposcopy
* body mass index (BMI) between 18 and 29
* regular menstrual cycles (21-35 days)
* absence of chronic diseases (hypertension, diabetes mellitus, cancer, depression, personality disorder, thyroid pat…
Contacts